The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> MEDICINE >> NEWS
Study shows symptom-driven therapy may be ok for some adults with mild persistent asthma

Some adults with mild persistent asthma may be able to adequately control their asthma by taking corticosteroids only when needed, instead of taking anti-inflammatory medication daily, according to new results from the Improving Asthma Control Trial (IMPACT). Conducted by the National Heart, Lung, and Blood Institute's (NHLBI) Asthma Clinical Research Network, the one-year, multi-center study found that participants who were treated with corticosteroids intermittently based on symptoms had about the same rate of severe exacerbations and of asthma-related lung function decline as those treated with the standard recommendation of daily long-term control medication.

Asthma is considered mild and persistent when individuals have acute symptoms such as wheezing, coughing, or chest tightness more than twice a week, but not daily, or they have night-time awakenings due to asthma more than two nights a month. The researchers caution that the new findings might not apply to people who have recently developed asthma. In addition, they do not apply to patients with more frequent symptoms or more severe asthma. The results are published in the April 14 issue of the New England Journal of Medicine.

"This study provides evidence of another possible way to treat adults with long-standing mild persistent asthma," stated Elizabeth G. Nabel, MD, director of the NHLBI, part of the National Institutes of Health. "If additional research confirms these findings, then some of these patients may be able to safely treat their asthma with intermittent medication and avoid the added expense and inconvenience of daily therapy. As for all asthma patients, however, individuals should work closely with their healthcare providers to develop and follow the treatment plan that suits them best."

More than 20 million Americans have asthma. For those with mild persistent asthma, guidelines from the National Asthma Edu
'"/>

Contact: NHLBI Communications Office
nhlbi_news@nhlbi.nih.gov
301-496-4236
NIH/National Heart, Lung, and Blood Institute
13-Apr-2005


Page: 1 2 3 4

Related medicine news :

1. Study, meta-analysis examine factors associated with death from heatstroke
2. Study says COPD testing is not measuring up
3. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
4. Study reveals gaps in vaccine financing for underinsured children
5. Study suggests nonpharmaceutical interventions may be helpful in severe influenza outbreaks
6. Study shows radiofrequency ablation highly effective in treating kidney tumors
7. Study says normal but out-of-control enzyme may be culprit that signals some cells to become cancer
8. Study finds HIV protease inhibitor drugs may adversely affect the scaffolding of the cell nucleus
9. Study outlines how stroke, head injury can increase risk of Alzheimers disease
10. Study identifies new regulator of fat metabolism
11. Study shows Diachrome improves blood sugar control in people with type 2 diabetes

Post Your Comments:
(Date:11/25/2009)...o signaling pathways essential to normal human dev...owth factor receptor (EGFR) pathways - interact in...astasis, researchers from The University of Texas ... issue of Molecular Cell . , This newly charact...ents known to correlate with invasive cancer - act...
(Date:11/25/2009)...ov. 25, 2009) Melvin R. Kaplan, MD, FACP, a forme...rch institute that became Los Angeles Biomedical R...A BioMed), will be honored by the American College...re of patients. , At its April 22, 2010 meeting ...l present Dr. Kaplan with the Ralph O. Claypoole S...
(Date:11/25/2009)...5, 2009 Physicians at UT Southwestern Medical Cen...ed to improve breathing in patients with upper spi... from breathing independently. , UT Southwester...y two sites in Texas and one of 25 in the country ...he NeuRx Diaphragm Pacing System. , The device i...
(Date:11/25/2009)...tify role mitochondrial function plays in insulin ...hDay News) -- Mitochondrial damage causes people w...s, a finding that could lead to new treatments, U....gy for cellular activity. , The researchers fou...ancreas can,t respond to circulating insulin, it t...
(Date:11/25/2009)... PCU College teaches students to use natu... , Burnaby, BC (Vocus) No... radiation are the standard, effective treatments ...o alternative medicine to help them cope with the ...creased number of cancer patients using acupunctur...
Breaking Medicine News(10 mins):Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 2Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 3Health News:1 of LA BioMed's founders to be honored 2Health News:New device implanted by surgeons help paralyzed patients breathe easier 2Health News:Holistic and Western Medicine Combined Can Fight Cancer 2
(Date:11/25/2009)...DIEGO,Nov.25/PRNewswire-FirstCall/--NuVasive,Inc.(...opingproductsforminimallydisruptivesurgicaltreatme...encecallonMonday,November30,2009,at5:30p.m.ET/2:30...lativetoreimbursementfortheCompany,sproductsandwil...tionandanswersession.Thedial-innumbersare1-877-407...
(Date:11/25/2009)...MINGHAM,Mass.andSYDNEY,Nov.25/PRNewswire-FirstCall...IN),aleadinginnovatorandprovideroflessinvasive,min...zingthetreatmentofadvancedheartfailure,todayannoun...the21stAnnualPiperJaffrayHealthCareConferenceat8:0...ingheldattheNewYorkPalaceHotel,December1-2. ,, ...
(Date:11/24/2009)...ISON,N.J.,Nov.24/PRNewswire-FirstCall/--QuestDiagn...oviderofdiagnostictesting,informationandservices,a...erJaffrayHealthcareConferenceinNewYorkCity.Thepres...30a.m.EasternTime. ,, Duringtheconference,theco...approximate3%,operatingincometoexceed18%ofrevenues...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2EnVivo Pharmaceuticals Announces Results and Successful Completion of EVP 6124 Phase Ib IIa Trial at the International Conference on Alzheimers Diseas 13042 1EnVivo Pharmaceuticals Announces Results and Successful Completion of EVP 6124 Phase Ib IIa Trial at the International Conference on Alzheimers Diseas 13042 2Rare Cells Linked to Pediatric Cancers 51764 1Rare Cells Linked to Pediatric Cancers 51764 2Stem Cell Decision Opens New Doors May Spur More Research 51762 1Stem Cell Decision Opens New Doors May Spur More Research 51762 2Stem Cell Decision Opens New Doors May Spur More Research 51762 3
Other News:
...5, 28 of the world's leading diabetes researchers ...Biological Sciences Learning Center, 924 E. 57th S...ebrate the 75th birthday of Donald F. Steiner, M.D... Molecular Biology and a member of the Howard Hugh...
ADULT lifestyle has more influence on your chances of developing diabetes than childhood experience, according to new research whose findings contradict previously-held beliefs. ......A team from the
...here is no specific PSA value that has both high s...lthy men for prostate cancer, but rather there is ...of PSA, according to a study in the July 6 issue o...ing activities in the United States is the measure...
...ol may allow healthcare professionals treating chi...more systematically sort out the combination of tr...hildren may improve over time. If the model holds ... to gauge the effectiveness of different autism tr...
health news:Steiner symposium brings together leading diabetes experts 2health news:Steiner symposium brings together leading diabetes experts 3health news:Adult lifestyle biggest risk factor for diabetes, study finds 2health news:Study examines accuracy of PSA values for detecting prostate cancer 2health news:Study examines accuracy of PSA values for detecting prostate cancer 3health news:New model may better predict outcomes for children with autism and autistic spectrum disorders 2health news:New model may better predict outcomes for children with autism and autistic spectrum disorders 3
...clinical trial for patients with advanced colorect...ontaining the investigational drug oxaliplatin liv...d therapy. Patients on the oxaliplatin regimen, k...ir tumors progressed, a better response rate, and ...
...ell, M.D., jokingly call their treatment table the... then a close brush with mortality entitles these ... they want....... Humor aside, they have come to t...st hope of preserving their lives, if not their br...
...EST) An experimental pill has been found to impro...on-small-cell lung cancer, according to research f...g Medical Director at Cedars-Sinai Comprehensive C...ill, called ZD 1839 (Iressa) is one of a new class...
...or inoperable primary liver cancer called TheraSph...cer patients, according to results presented by a ...nual Meeting of the American Society for Clinical ...fessor and director of the liver tumor service at ...
health news:New drug regimen shows clear benefit for treating advanced colorectal cancer 2health news:New drug regimen shows clear benefit for treating advanced colorectal cancer 3health news:New breast cancer therapy trials show dramatic results 2health news:New breast cancer therapy trials show dramatic results 3health news:New breast cancer therapy trials show dramatic results 4health news:New breast cancer therapy trials show dramatic results 5health news:Experimental pill found to improve symptoms in patients with non-small-cell lung cancer 2health news:Experimental pill found to improve symptoms in patients with non-small-cell lung cancer 3health news:New treatment reduces liver tumors and improves quality of life for cancer patients 2